ClinConnect ClinConnect Logo
Search / Trial NCT00157339

Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD

Launched by ELI LILLY AND COMPANY · Sep 7, 2005

Trial Information

Current as of May 20, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Type 1 or type 2 diabetes
  • asthma or COPD
  • Exclusion Criteria:
  • Current smoking habit

About Eli Lilly And Company

Eli Lilly and Company is a global healthcare leader dedicated to creating innovative medicines that improve patient outcomes across a range of therapeutic areas, including diabetes, oncology, immunology, and neurodegenerative diseases. With a rich history of scientific research and a commitment to advancing healthcare, Lilly invests significantly in clinical trials to develop new treatments and enhance existing therapies. The company prioritizes patient safety and ethical standards in its clinical research, fostering collaboration with healthcare professionals and stakeholders to ensure the delivery of high-quality, evidence-based solutions that address unmet medical needs worldwide.

Locations

Jacksonville, Florida, United States

Montgomery, Alabama, United States

Greenbrae, California, United States

West Palm Beach, Florida, United States

Norfolk, Virginia, United States

Sainte Foy, Quebec, Canada

P.O Ernakulam, , India

San Antonio, Texas, United States

Burbank, California, United States

Norwich, Connecticut, United States

Clearwater, Florida, United States

Hollywood, Florida, United States

New Port Richey, Florida, United States

Ocala, Florida, United States

Belvidere, Illinois, United States

Chicago, Illinois, United States

Springfield, Illinois, United States

Topeka, Kansas, United States

Louisville, Kentucky, United States

Baltimore, Maryland, United States

Brockton, Massachusetts, United States

Omaha, Nebraska, United States

Las Vegas, Nevada, United States

Charlotte, North Carolina, United States

Morehead City, North Carolina, United States

Kettering, Ohio, United States

Medford, Oregon, United States

Downingtown, Pennsylvania, United States

Levittown, Pennsylvania, United States

Sellersville, Pennsylvania, United States

Simpsonville, South Carolina, United States

Spartanburg, South Carolina, United States

Sioux Falls, South Dakota, United States

El Paso, Texas, United States

Houston, Texas, United States

Humble, Texas, United States

Midland, Texas, United States

Tacoma, Washington, United States

Buenos Aires, , Argentina

Cordoba, , Argentina

Mendoza, , Argentina

Ramos Mejia, , Argentina

Haskovo, , Bulgaria

Pazardzhik, , Bulgaria

Pleven, , Bulgaria

Plovdiv, , Bulgaria

Sofia, , Bulgaria

Stara Zagora, , Bulgaria

Winnipeg, Manitoba, Canada

St Johns, Newfoundland And Labrador, Canada

Corunna, Ontario, Canada

Niagara Falls, Ontario, Canada

Sarnia, Ontario, Canada

Longueuil, Quebec, Canada

San Miguel, , Chile

Vina Del Mar, , Chile

Bogota, , Colombia

Zagreb, , Croatia

Kwun Tong, , Hong Kong

Budapest, , Hungary

Eger, , Hungary

Gyula, , Hungary

Kalocsa, , Hungary

Kecskemet, , Hungary

Nyiregyhaza, , Hungary

Szekesfehervar, , Hungary

Szolnok, , Hungary

Ahmedabad, , India

Bangalore, , India

Chennai, , India

Cochin, , India

Coimbatore, , India

Gandhinagar, , India

Hyderabaad, , India

Kolkatta, , India

Kormangala, , India

Mangalore, , India

Mumbai, , India

Nagpur, , India

New Delhi, , India

Noida, , India

Porur, , India

Pune, , India

Secunderabad, , India

Tamil Nadu, , India

Vellore, , India

Mexico City, , Mexico

Monterrey, , Mexico

Barangay Pembo, , Philippines

Dillman, , Philippines

Ermita, , Philippines

Espana, , Philippines

Manila, , Philippines

Pasig City, , Philippines

Quezon City, , Philippines

San Juan, , Philippines

Ponce, , Puerto Rico

Singapore, , Singapore

Taichung, , Taiwan

Bangkoknoi, , Thailand

Bangkok, , Thailand

Patients applied

0 patients applied

Trial Officials

Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon-Fri 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hour, EST)

Study Director

Eli Lilly and Company

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials